Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Innovation Pharmaceuticals Inc IPIX

Innovation Pharmaceuticals Inc. is a clinical stage pharmaceutical company developing therapies with anti-infective, oncology, anti-inflammatory and dermatology applications. The Company’s lead drug candidate, Brilacidin, is in a class of compounds called defensin-mimetics, small compounds that mimic the structure and function of defensins, also known as host defense peptides. The Company is... see more

GREY:IPIX - Post Discussion

Innovation Pharmaceuticals Inc > Abnormal volume and price!
View:
Post by kaos12 on Jan 29, 2018 5:54pm

Abnormal volume and price!

This is what I’ve been waiting for. Today’s news will have to reprice IPIX now, it was outstanding. Have known of IPIX for a little while and just couldn’t figure out why it wasn’t moving.  Amazing products. Obviously today’s news got the attention we need. Have heard that the people in the trials who were given the medications wanted to stay on the program after it was finished. We’re getting looked at and our share price should reflect how hard the looks are. Good combo news release with successful trials and partnering up with some adept people. Great company products for numerous ailments. Got started today accumulating shares.
Comment by aragon1959 on Jan 30, 2018 4:13pm
agree with you 100% Kaos I am waiting for FDA approval of Brilacidin for OM No standard of treatment in OM so they dont need phase III trial 1-10 bln $ market Exciting times GLTA
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities